196 related articles for article (PubMed ID: 21373759)
1. Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.
Pennington PR; Wei Z; Rui L; Doig JA; Graham B; Kuski K; Gabriel GG; Mousseau DD
J Neural Transm (Vienna); 2011 Jul; 118(7):987-95. PubMed ID: 21373759
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex.
Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD
J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.
Cao X; Wei Z; Gabriel GG; Li X; Mousseau DD
BMC Neurosci; 2007 Sep; 8():73. PubMed ID: 17868476
[TBL] [Abstract][Full Text] [Related]
5. Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.
Wei Z; Satram-Maharaj T; Chaharyn B; Kuski K; Pennington PR; Cao X; Chlan J; Mousseau DD
J Neural Transm (Vienna); 2012 Nov; 119(11):1285-94. PubMed ID: 22382901
[TBL] [Abstract][Full Text] [Related]
6. Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice.
Xie J; Chang X; Zhang X; Guo Q
Brain Res; 2001 Oct; 915(1):1-10. PubMed ID: 11578614
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.
Manzoor S; Hoda N
Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081
[TBL] [Abstract][Full Text] [Related]
8. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
9. Parkin suppresses the expression of monoamine oxidases.
Jiang H; Jiang Q; Liu W; Feng J
J Biol Chem; 2006 Mar; 281(13):8591-9. PubMed ID: 16455660
[TBL] [Abstract][Full Text] [Related]
10. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
11. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
Klegeris A; McGeer PL
Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
[TBL] [Abstract][Full Text] [Related]
12. Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease.
Chan-Palay V; Höchli M; Savaskan E; Hungerecker G
Dementia; 1993; 4(1):1-15. PubMed ID: 8358501
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex.
Quartey MO; Nyarko JNK; Pennington PR; Heistad RM; Klassen PC; Baker GB; Mousseau DD
Front Neurosci; 2018; 12():419. PubMed ID: 29997470
[TBL] [Abstract][Full Text] [Related]
14. Presenilin-1 inhibits delta-catenin-induced cellular branching and promotes delta-catenin processing and turnover.
Kim JS; Bareiss S; Kim KK; Tatum R; Han JR; Jin YH; Kim H; Lu Q; Kim K
Biochem Biophys Res Commun; 2006 Dec; 351(4):903-8. PubMed ID: 17097608
[TBL] [Abstract][Full Text] [Related]
15. Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.
Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
J Neural Transm (Vienna); 2013 Mar; 120(3):435-44. PubMed ID: 22968599
[TBL] [Abstract][Full Text] [Related]
16. Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2.
Wang W; Moerman-Herzog AM; Slaton A; Barger SW
Neurobiol Aging; 2017 Jan; 49():145-153. PubMed ID: 27810638
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo.
Mickey BJ; Ducci F; Hodgkinson CA; Langenecker SA; Goldman D; Zubieta JK
J Neurosci; 2008 Oct; 28(44):11354-9. PubMed ID: 18971477
[TBL] [Abstract][Full Text] [Related]
18. Iron modulates the activity of monoamine oxidase B in SH-SY5Y cells.
Lu H; Chen J; Huang H; Zhou M; Zhu Q; Yao SQ; Chai Z; Hu Y
Biometals; 2017 Aug; 30(4):599-607. PubMed ID: 28685208
[TBL] [Abstract][Full Text] [Related]
19. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta.
Shimojo M; Sahara N; Mizoroki T; Funamoto S; Morishima-Kawashima M; Kudo T; Takeda M; Ihara Y; Ichinose H; Takashima A
J Biol Chem; 2008 Jun; 283(24):16488-96. PubMed ID: 18430735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
